SplitJul 15, 2026, 01:47 PM
LataMed AI's 5-for-1 Forward Stock Split Becomes Effective
AI Summary
LataMed AI Corp. announced that its previously declared 5-for-1 forward stock split became effective on July 15, 2026. The company's common stock will trade under the temporary symbol LMEDD for approximately 20 business days, after which it is expected to revert to LMED. This action also includes a new CUSIP number, 21116R404, with the prior CUSIP being suspended. CEO Kevin Rodan Levy highlighted the split as an important corporate milestone, supporting the company's strategy to expand its telemedicine and AI platforms.
Key Highlights
- LataMed AI's 5-for-1 forward stock split became effective on July 15, 2026.
- Common stock will trade under temporary symbol LMEDD for approximately 20 business days.
- New CUSIP number is 21116R404; prior CUSIP 21116R305 is suspended.
- Shareholders holding shares through brokerage accounts are not required to take action.
- CEO Kevin Rodan Levy stated the split is an "important corporate milestone."
- Company plans to expand its telemedicine platform and AI platforms (CardioAI, PulmoAI, NeuroAI).
Price Impact
More from CCTC